Send-in sample collection study for immune response to respiratory viruses
Part of Infections, Lungs & breathing clinical trials.
This study collects sent-in samples to better understand how your immune system responds during a COVID-19–like illness and after you recover. It may help researchers learn why some people get sick and others stay uninfected, and how immune protection works over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be any age from newborn to 99 years old
- You either have (or might have) COVID-19 or a similar respiratory virus, or you are not infected despite heavy exposure, or you are a close family member of someone in the study
- If you are being enrolled as uninfected or as a relative, you must be able to agree to the study (informed consent)
- You must be willing to do genetic testing
- You must be willing to have your samples and data stored for future research
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects samples from people who have or might have a cold/respiratory virus, then stores them for future research. It may help researchers better understand respiratory germs and develop better treatments.
This observational study looks for digital health patterns during studies where people are intentionally exposed to a respiratory virus. If you join a respiratory virus challenge at NIH, you may help researchers discover better ways to monitor and understand illness using wearable devices and shared health data.
This trial studies how viruses affect the body, and how the immune system responds, in both healthy people and people with weakened immunity. It may include people who currently have a suspected or recent viral infection, close contacts, people around the time of a viral vaccine, and healthy adults used for comparison.
This study looks at how your immune system responds to COVID-19 or the flu. It may help researchers understand these infections better, whether you are currently sick or healthy.
This study collects samples from people who currently have, recently had, or may have been exposed to common respiratory viruses. The goal is to use these samples to develop and test future countermeasures (like treatments) against COVID-19 and other viruses.
This study looks at how the immune system in the body responds to different COVID-19 virus variants. It may help improve how COVID-19 is diagnosed by comparing people who are currently infected and those who are not.
Hear when a new COVID-19 Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.